Institute of Cancer and Genomic Sciences Using fundamental research and the power of genomics to develop better therapies in cancer and other complex diseases.
News TREATWolfram clinical trial to unlock a potential treatment for a rare disease Birmingham is making a real-world impact on rare diseases, with a comprehensive multi-facility network for research helping to find new treatments for patients like those with Wolfram syndrome.
News Stopping the awakening of sleeping Acute Myeloid Leukaemia stem cells to prevent disease relapse
News Cancer Research UK Clinical Trials Unit: Celebrating 40 Years of Funding From Cancer Research UK
08 November 2023 Rare disease trials to develop playbook for testing new treatments MRC and NIHR funded project to develop new 'one-stop-study' method for running clinical trials with all phases included.
08 November 2023 Hodgkin Lymphoma: small cause - big effect The exchange of a single amino acid in a transcription factor dramatically changes gene regulation to switch normal B-cells into cancer cells.
12 September 2023 Round of Successful Grant Applications for the Institute of Cancer and Genomic Sciences Professor Jo Parish, Professor Aga Gambus and Dr Clare Davies have been successful in securing over one million pounds in grant applications.
11 September 2023 New Appointments: Professor Guy Pratt This Summer we welcomed Professor Guy Pratt to the Institute of Cancer and Genomics.
25 July 2023 ICGS has three new Professors The Institute of Cancer and Genomic Sciences has three new Professors: Eva Petermann, Aga Gambus and Simon Bach.
25 July 2023 Vaccine rollout cut Covid deaths for cancer patients by 84% New two year UK-wide study finds Covid-19 risk for cancer patients still higher than general population, but fell following availability of vaccinations in 2021